External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

Prostate cancer incidence and mortality trends in 37 European countries: An overview

(2010) F. Bray et al.   EUROPEAN JOURNAL OF CANCER

Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study

(2010) Takashi Saika et al.   WORLD JOURNAL OF UROLOGY

Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975

(2009) C. La Vecchia et al.   ANNALS OF ONCOLOGY

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms

(2009) Dirk Zaak et al.   BJU INTERNATIONAL

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

(2009) Jesus Fernandez-Gomez et al.   JOURNAL OF UROLOGY

Safety of Active Surveillance Program for Recurrent Nonmuscle-invasive Bladder Carcinoma

(2009) V. Hernández et al.   UROLOGY

New therapies for non-muscle-invasive bladder cancer

(2009) Edmund Chiong et al.   WORLD JOURNAL OF UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

The present and future burden of urinary bladder cancer in the world

(2009) Martine Ploeg et al.   WORLD JOURNAL OF UROLOGY